JP Morgan Chase’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

JP Morgan Chase’s Portfolio ISLE Stock Details ISLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,744	Closed	-$217K	–	7148
2022 Q2	$217K	Sell	21,744 -410,100	-95%	-$4.07M	﹤0.01%	5040
2022 Q1	$4.28M	Sell	431,844 -211,128	-33%	-$2.08M	﹤0.01%	3142
2021 Q4	$6.33M	Sell	642,972 -29,040	-4%	-$286K	﹤0.01%	2855
2021 Q3	$6.61M	Sell	672,012 -206	-0%	-$2.01K	﹤0.01%	2786
2021 Q2	$6.59M	Sell	672,218 -1,600	-0.2%	-$15.6K	﹤0.01%	2803
2021 Q1	$6.53M	Buy	+673,818	New	+$6.51M	﹤0.01%	2757

JP Morgan Chase's ISLE Position: Q3 2022 in Review

JP Morgan Chase sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 21,744 shares — an estimated $217K sold.

JP Morgan Chase first reported a position in ISLE in Q1 2021 and held it in 6 quarters. The position peaked at $6.61M in Q3 2021. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

JP Morgan Chase reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
JP Morgan Chase sold 21,744 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $217K.
JP Morgan Chase first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 6 quarters.
JP Morgan Chase's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $6.61M in Q3 2021.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.